Logo image
Open Research University homepage
Surrey researchers Sign in
Apoptotic effects of the tyrosine kinase inhibitor, masitinib mesylate, on canine osteosarcoma cells
Journal article   Peer reviewed

Apoptotic effects of the tyrosine kinase inhibitor, masitinib mesylate, on canine osteosarcoma cells

CE Fahey, RJ Milner, K Kow, NJ Bacon and ME Salute
ANTI-CANCER DRUGS, Vol.24(5), pp.519-526
01/06/2013

Abstract

Science & Technology Life Sciences & Biomedicine Oncology Pharmacology & Pharmacy ONCOLOGY PHARMACOLOGY & PHARMACY canine osteosarcoma comparative oncology masitinib mesylate tyrosine kinase inhibitor DOXORUBICIN COMBINATION CHEMOTHERAPY SIGNAL-TRANSDUCTION INHIBITION APPENDICULAR OSTEOSARCOMA GROWTH-FACTOR IN-VITRO OSTEO-SARCOMA NUDE-MICE DOGS AMPUTATION CISPLATIN
url
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000317392100009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View
Author

Metrics

Details

Logo image

Usage Policy